Precision Medicine

Bristol-Myers Squibb Co. (BMS) said that it has entered into a $1 billion deal with Danish biotechnology company Bavarian Nordic for rights to a late-stage prostate cancer vaccine. The companies entered into an agreement that provides BMS an exclusive option to license and commercialize Prostvac, Bavarian Nordic’s investigational Phase III …

Rare disease maker Alexion Pharmaceuticals has partnered with Blueprint Medicines to develop drugs for a rare genetic disease. Blueprint Medicines said that the companies have formed a strategic collaboration to discover, develop and commercialize novel drug candidates for an undisclosed activated kinase target, which causes a rare genetic disease. Blueprint …

DNAnexus Inc., a pioneer in cloud-based genome informatics and data management, recently announced that Intermountain Cancer Genomics is now utilizing its technology platform for the center’s personalized treatment options for cancer patients. The DNAnexus platform allows Intermountain Cancer Genomics to run its bioinformatics pipeline in the cloud, providing unmatched computational …

The Oncology Research Information Exchange Network (ORIEN), founded by Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCC-James), announced that it has expanded with the addition of four nationally recognized cancer centers. ORIEN, a research …

Today, Foundation Medicine, Inc. and H3 Biomedicine Inc. announced that they will collaborate to develop precision therapies for cancer. The companies said that they have entered a multi-year collaboration for the discovery and development of precision medicines in oncology, utilizing Foundation Medicine’s comprehensive genomic knowledgebase of more than 35,000 genomic …

Researchers have released a precision medicine approach to diabetes prevention that could identify individuals at the highest risk for developing the disease and who stand to gain the most from a diabetes-preventing drug. A new model examined 17 different health factors, in an effort to predict who is likely to …

In an effort to personalize medicine, Wake Forest Baptist Medical Center announced a new Precision Medicine program at its cancer center. Precision medicine, introduced to the nation during President Barack Obama’s State of the Union address, uses a person’s unique genetic makeup to develop an individualized treatment plan. For cancer, …

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, in collaboration with Northwestern Medicine Developmental Therapeutics Institute (NMDTI) and Northwestern Memorial Hospital, has launched a new research program aimed at providing precision medicine to cancer patients. The companies announced the launch of Northwestern Onco-SET (Sequence, Evaluate, Treat) to provide …

Following up on President Barack Obama’s announcement in his State of the Union Address, the Administration unveiled details about the Precision Medicine Initiative, including plans to collect genetic data on one million Americans. On Friday, Obama gave more details about the initiative that he originally announced during his State of …

During the State of the Union address, President Barack Obama announced his new “Precision Medicine” initiative to deliver new and more effective treatments for diseases, such as cancer and diabetes. In his address, Obama urged Congress to increase research funding to support investments in precision medicine, a growing field of …